-
for the Swedish contribution to an international project on the safety of new pharmacological treatments for MS. Eligibility requirements The candidate should have at least 2 years of experience from working with
-
in research and education Do you want to contribute to improving human health? At the Department of Physiology and Pharmacology we teach and conduct internationally acclaimed, high quality research
-
Do you want to contribute to top quality medical research? We need to expand our group working within a project aiming to identify pharmacologically active substances from traditional Chinese
-
, medicine, biomedicine, pharmacology, or nutrition. Good knowledge and training in GCP (Good Clinical Practice) as well as the laws/regulations and guidelines that underpin how clinical studies of various
-
, peripheral tissues and blood of Alzheimer’s disease pre-clinical mice models and clinical samples. To check the effect of therapeutic treatment with neurotrophins and pharmacological studies using in-vitro
-
, the mechanism of action of lithium and the ability of lithium to become the first pharmacological treatment for cranial radiotherapy-induced cognitive impairment. For this project, we are looking for a clinical
-
. The group is focused on targets and pathways in rheumatic and related diseases driven by inflammation using a pharmacological approach. In collaboration with Uppsala University and Guangdong Provincial
-
, at Dept. Physiology and Pharmacology, Karolinska Institutet. The group works in an inspiring and interactive research environment in Biomedicum at Campus Solna (see https://staff.ki.se/biomedicum-for-staff
-
excellent communication and organizational skills. Proficiency in oral and written English is necessary. Applicants should hold a masters' degree (or equivalent) in medicine, biology, pharmacology or another
-
these tumors by pharmacological approach utilizing small molecule inhibitors. Furthermore, the Arsenian-Henriksson’s Lab is interesting in understating the development and cell of origin of neuroblastoma using